Related Experiment Video
Updated: Nov 18, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Risk assessment and prognostic aspect of coagulopathy in COVID-19
Mujibur Rahman1, Nadira Naznin Rakhi2
1Department of Biotechnology and Genetic Engineering, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh.
Insights
The COVID-19 pandemic has led to increased blood clotting issues (coagulopathy), raising mortality risks. Understanding these coagulation changes in severe cases is crucial for effective patient management and improved outcomes.
Area of Science:
- * Hematology and Infectious Diseases: Investigating the intersection of viral infections and blood coagulation disorders.
Background:
- * The global spread of SARS-CoV-2 (COVID-19) has resulted in a pandemic with significant morbidity and mortality.
- * COVID-19 patients frequently exhibit blood coagulopathy, contributing to organ dysfunction and increased fatality rates.
Discussion:
- * Alterations in coagulation function due to COVID-19 elevate the risk of pulmonary embolism and deep vein thrombosis.
- * Elevated D-dimer levels and fibrin degradation products are commonly observed, particularly in severe COVID-19 cases.
Key Insights:
- * COVID-19 significantly impacts blood coagulation, leading to life-threatening thrombotic events.
- * Severe COVID-19 cases show distinct coagulopathy patterns compared to non-severe cases, necessitating tailored treatment approaches.
Outlook:
- * Further research is needed to elucidate the precise mechanisms of COVID-19-induced coagulopathy.
- * Developing targeted management strategies for COVID-19-related coagulation disorders is essential for improving patient prognosis and reducing mortality.
Abstract:
Since December 2019, the rapid spread of SARS CoV-2 across the border, shuffled into a world pandemic situation with an alarming rate of morbidity and mortality. Concerns are mounting as the reports indicate tangled circumstances among the COVID-19 patients due to blood coagulopathy followed by organ dysfunction. COVID-19 induced an alteration in coagulation function increase the risk of pulmonary embolism and deep vein thrombosis associated with poor prognosis as well as high mortality. An elevated level D-dimer and other fibrin degrading protein are documented among the patients with COVID-19; especially in severe cases. Differences in coagulopathy among severe and non-severe cases, required prompt attention to adopt a more effective management strategy.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Coagulation
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
